Local Anesthetic Wound Infiltration after Osteosynthesis of Extracapsular Hip Fracture Does Not Reduce Pain or Opioid Requirements: A Randomized, Placebo-Controlled, Double-Blind Clinical Trial in 49 Patients.
Rune Dueholm BechOle OvesenJens LauritsenClaus EmmeluthPeter LindholmSøren OvergaardPublished in: Pain research & management (2018)
Ropivacaine as single component in postoperative treatment of pain after hip fracture is not effective. In our setup, wound infiltration with ropivacaine is not statistically significantly better than placebo.
Keyphrases
- hip fracture
- double blind
- placebo controlled
- chronic pain
- clinical trial
- pain management
- phase iii
- end stage renal disease
- phase ii
- neuropathic pain
- study protocol
- postoperative pain
- chronic kidney disease
- newly diagnosed
- ejection fraction
- prognostic factors
- randomized controlled trial
- peritoneal dialysis
- phase ii study
- squamous cell carcinoma
- open label
- spinal cord injury
- radiation therapy
- spinal cord
- patient reported outcomes
- combination therapy